Atrial fibrillation (AF) continues to be a leading cause of cerebrovascular morbidity and
mortality resulting from cardioembolic stroke. Oral anticoagulation therapy has been shown to …

… excluded because per-patient per-year costs could not be measured by using the reported
data (most commonly because the data were reported as part of a cost-utility study). Twenty-…

… Atrial Fibrillation Screening Strategies Eight atrial fibrillation (AF) screening strategies evaluated
in our cost-… All event rate, utility, and cost parameters are listed in eTables 1 to 7 in the …

… A utility value calculated for a 2009 CEA was 0.725 for patients having AF, with a 0.065
post-… for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analysis. …

… Health-Related Quality of Life and Utilities We awarded utilities to each simulated patient
to estimate QALY. Major or minor neurological events (major or minor, stroke, or ICH) were …

… cost data also contained costs for repeat occurrences. To avoid double counting costs and
utility reductions due to stroke, patients … neither additional costs nor utility decrements when …

… Costs and utilities were assigned to each state as well as to the … cost data were based on
published local data, official price lists, clinical guidelines and product labels. Data for utilities …

… In this cost-utility analysis, we found that monitoring CS patients for three years using an
ICM is cost-effective for the prevention of recurrent stroke, compared to SoC. An ICER of £…

… Therefore, there may be a trade-off between higher costs and … the cost-effectiveness of
treating paroxysmal AF patients with … Each health state is associated with different costs, utilities, …

… utility value calculation are not a complete match for our study cohort and intervention. However,
we think the utility … state in this study, the gain in utility value may even be a conservative …